Multiple Myeloma & Rare Blood Cancers: Living with Multiple Myeloma, Patient Access to Care, and Innovations in Treatment

savethedate_graphic2 September 18, 2013 at 10 a.m. EST in 234 Cannon House Office Building

Please join CHI for an informational Congressional briefing on multiple myeloma and rare blood cancers. Approximately 22,350 Americans will be diagnosed with new cases of multiple myeloma in 2013.

The briefing will provide Members of Congress and staff with information about the underlying science of blood cancers, the importance of new innovations in treatment, the vital process through which cancer patients access clinical trials, the integral role of patient advocates in helping cancer patients navigate their treatments and care, and how patients and advocates are preparing for changed insurance marketplaces.

Our expert panelists include:

RSVP to Jenny Carey, CHI’s associate director of federal relations and programs ( or 202-974-6323)

Download Invitation

This event is held in strict accordance with House and Senate Ethics rules.  Food and refreshments of a nominal value will be provided as allowed by House Rule 25, clause 5(a)(3)(U) and Senate Rule 35.1(d)(1).

This informational briefing is made possible through an educational grant from Onyx Pharmaceuticals.